MiR-206 restoration improved the cisplatin sensitivity in NSCLC cell lines and discouraged the potential of EMT, invasion, and migration by silencing MET gene expression, and repressing the PI3k/Akt/mTOR signaling pathway [254]. Here, MTOR is linked to non-small cell lung carcinoma.